Cresco Labs Inc.
CRLBF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $471,788 | $182,001 | $253,926 | $318,982 |
| - Cash | $45,413 | $146,609 | $155,354 | $137,564 |
| + Debt | $580,760 | $630,906 | $645,726 | $639,641 |
| Enterprise Value | $1,007,135 | $666,298 | $744,298 | $821,059 |
| Revenue | $164,913 | $163,624 | $165,757 | $174,420 |
| % Growth | 0.8% | -1.3% | -5% | – |
| Gross Profit | $79,360 | $83,256 | $78,631 | $82,537 |
| % Margin | 48.1% | 50.9% | 47.4% | 47.3% |
| EBITDA | $19,871 | $30,677 | $29,447 | $32,427 |
| % Margin | 12% | 18.7% | 17.8% | 18.6% |
| Net Income | -$17,054 | -$16,334 | -$14,432 | -$4,372 |
| % Margin | -10.3% | -10% | -8.7% | -2.5% |
| EPS Diluted | -0.048 | -0.046 | -0.041 | -0.013 |
| % Growth | -3% | -12.2% | -226.2% | – |
| Operating Cash Flow | $6,164 | $8,831 | $30,463 | $29,486 |
| Capital Expenditures | -$7,558 | -$13,296 | -$7,035 | -$3,487 |
| Free Cash Flow | -$1,394 | -$4,465 | $23,428 | $25,999 |